Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 69097-173

7 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 69097-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1 (Structure 1)

Fig 1 (Structure 1)
Chemical structure diagram depicting the molecular formula of Albuterol Sulfate, showing atom connections including hydroxyl and amine groups as part of the compound.*
FDA Label Image

Fig 2 (Structure 2)

Fig 2 (Structure 2)
Chemical structure of Ipratropium Bromide, an active ingredient in the Ipratropium Bromide and Albuterol Sulfate respiratory inhalation solution. The diagram shows molecular bonds and functional groups including a quaternary ammonium group and bromide with water molecule (H2O).*
FDA Label Image

3 (914605d4 7326 445d B20e 6771eb67f7c4 03)

3 (914605d4 7326 445d B20e 6771eb67f7c4 03)
A line graph comparing lung function (liters) over 8 hours after dosing for Albuterol, Ipratropium, and Ipratropium Bromide and Albuterol Sulfate Inhalation Solution. The graph shows lung volume on the vertical axis and time in hours since dosing on the horizontal axis.*
FDA Label Image

Image 1 (Step1)

Image 1 (Step1)
Instructional illustration shows four steps for using a vial of Ipratropium Bromide and Albuterol Sulfate respiratory inhalation solution. Steps include tearing one vial from the combipack, twisting off the vial cap, squeezing the solution into the nebulizing chamber reservoir, and discarding the vial after use.*
FDA Label Image

Image 2 (Step 2)

Image 2 (Step 2)
An instructional illustration depicting a hand holding a respiratory inhalation device and inserting or removing a small, ribbed cap or component from the top of the device. This figure appears to demonstrate a step related to preparing or maintaining the inhalation solution device.*
FDA Label Image

Image 3 (Step 3)

Image 3 (Step 3)
Two black-and-white instructional illustrations for using a respiratory inhalation solution. Figure 3 shows a person holding an inhaler mouthpiece with their lips around it, while Figure 4 shows the person using a mask attached to the inhaler over their nose and mouth, indicating different methods of inhalation administration for Ipratropium Bromide and Albuterol Sulfate solution.*
FDA Label Image

0pt5mg And 3mg (Label)

0pt5mg And 3mg (Label)
Carton label for Ipratropium Bromide and Albuterol Sulfate inhalation solution USP 0.5 mg and 3 mg per 3 mL, prediluted sterile unit-dose vials for inhalation only. The label includes the product name, strengths, dosage form, usage instructions as unit-dose vials, and the Cipla USA Inc. labeler name. It shows multiple panels of the unfolded carton with NDC 69097-173-53 and regulatory notes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.